NCT00816491

Brief Summary

The primary endpoint of the study will be to compare the accuracy of two procedures (FICE with target biopsies only, versus conventional white light colonoscopy with recommended targeted and random biopsies) in the endoscopic surveillance of patient with long-standing UC. Accuracy will be measured based on the number of patients with confirmed neoplasia using each technique. The combined histological outcome following the two procedures will represent the gold-standard diagnosis for each patient. Secondary outcomes will be the number of patients with false-positive findings, the number of neoplastic lesions detected, the number of false-positive lesions per patient for each technique and the total time required for each procedure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2008

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 31, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 1, 2009

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 26, 2011

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2013

Completed
Last Updated

June 1, 2022

Status Verified

May 1, 2022

Enrollment Period

3 years

First QC Date

December 31, 2008

Last Update Submit

May 30, 2022

Conditions

Keywords

patient with long-standing UC

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint of the study will be to compare the accuracy of two procedures (FICE with target biopsies only, versus conventional white light colonoscopy)

    3 months between FICE and Conventional white light colonoscopy

Secondary Outcomes (2)

  • The goal is to detect more and earlier neoplastic lesions in order to influence patient management in terms of treatment (potential colectomy) and surveillance.

    3 months between FICE and Conventional white light colonoscopy

  • To quantify the number of true positive and false positive lesions by comparing the number of targeted biopsies performed for suspicious lesions and the resulting histological findings.

    3 months between FICE and Conventional white light colonoscopy

Study Arms (2)

A

ACTIVE COMPARATOR

Conventional white light colonoscopy

Device: conventional white light colonoscopy

B

EXPERIMENTAL

Chromoendoscopy

Device: FICE (Fujinon Intelligent Chromoendoscopy)

Interventions

conventional white light colonoscopy

A

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinically and histologically verified UC
  • Disease duration ≥ 8 years
  • A Mayo score ≤ 8 with an endoscopic sub score ≤ 2
  • CPAM affiliation
  • Able to give written informed consent to participate in the study

You may not qualify if:

  • Known intraepithelial neoplasia or colorectal cancer or any other active malignancy
  • Previous colo-rectal surgery
  • Non-treatable coagulopathy or hemostatic dysfunction (prothrombin index \< 50% of control or/and partial thromboplastin time \> 50 seconds and/or thrombopenia \< 60000 / mm3)
  • Pregnancy
  • Inability to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Departement d'Endoscopie digestive - Hopital Archet 2, CHU de Nice

Nice, 06202, France

Location

MeSH Terms

Conditions

Colitis, Ulcerative

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesInflammatory Bowel DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Geoffrey VANBIERVLIET, PH

    Departement d'Endoscopie digestive, CHU de Nice

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 31, 2008

First Posted

January 1, 2009

Study Start

October 1, 2008

Primary Completion

September 26, 2011

Study Completion

November 9, 2013

Last Updated

June 1, 2022

Record last verified: 2022-05

Locations